April 10, 2024 Critical Path Institute Announces New Board Members Bonnie A. Allin and Louis Breton Critical Path Institute (C-Path) today announced the appointments of Bonnie A. Allin and Louis Breton to its Board of Directors.
March 28, 2024 C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of...
March 26, 2024 C-Path Launches Consortium for Alpha-1 Antitrypsin Deficiency Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency...
March 25, 2024 C-Path to Spearhead New Task Force Dedicated to Accelerating Drug Development for Progressive Supranuclear Palsy Critical Path Institute (C-Path) today announced the formation of a new task force...
March 15, 2024 C-Path’s CURE Drug Repurposing Collaboratory Aims to Document 1,000 Cases on the CURE ID App for Long COVID Awareness Day TUCSON, Ariz., March 15, 2024 — Critical Path Institute’s (C-Path) CURE Drug Repurposing Collaboratory (CDRC), a leading advoc
March 14, 2024 Improving Data Collection for Rare Epilepsies: Case example from the TSC Natural History Presented by Elizabeth Cassidy, MPH from TSC Alliance...
March 8, 2024 Rare Neurodegenerative Disease Efforts Under the ACT for ALS In this webinar from The Critical Path Institute’s Rare and Orphan Disease Program CP-RND consortium, members discuss...
March 5, 2024 C-Path Wraps Up Productive Leadership Retreat, In-Person Meetings Critical Path Institute proudly recruits elite talent from across the globe, supporting remote work and a healthy work-life balanc
February 15, 2024 C-Path Launches Revamped Website to Enhance Collaborations in Drug Development Critical Path Institute (C-Path) today officially launched its newly revamped website, designed to further enhance collab...
